(Q43202669)
Statements
1 reference
Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs (English)
1 reference
Benjamin Druss
1 reference
Elaine H Morrato
1 reference
Daniel M Hartung
1 reference
Robert J Valuck
1 reference
Richard Allen
1 reference
Elizabeth Campagna
1 reference
John W Newcomer
1 reference
1 January 2010
1 reference
1 reference
67
1 reference
1
1 reference
17-24
1 reference
Identifiers
1 reference
1 reference